Search by Drug Name or NDC

    NDC 00003-2814-11 ORENCIA 50 mg/.4mL Details

    ORENCIA 50 mg/.4mL

    ORENCIA is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E.R. Squibb & Sons, L.L.C.. The primary component is ABATACEPT.

    Product Information

    NDC 00003-2814
    Product ID 0003-2814_ca83b90c-3ec0-4803-bf69-18c035bc41f0
    Associated GPIs 6640001000E510
    GCN Sequence Number 077399
    GCN Sequence Number Description abatacept SYRINGE 50MG/0.4ML SUBCUT
    HIC3 S2Q
    HIC3 Description ANTINFLAMMATORY, SEL.COSTIM.MOD.,T-CELL INHIBITOR
    GCN 43389
    HICL Sequence Number 037825
    HICL Sequence Number Description ABATACEPT
    Brand/Generic Brand
    Proprietary Name ORENCIA
    Proprietary Name Suffix n/a
    Non-Proprietary Name abatacept
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route SUBCUTANEOUS
    Active Ingredient Strength 50
    Active Ingredient Units mg/.4mL
    Substance Name ABATACEPT
    Labeler Name E.R. Squibb & Sons, L.L.C.
    Pharmaceutical Class Decreased Cytokine Activity [PE], Recombinant Fusion Proteins [CS], Selective T Cell Costimulation Modulator [EPC]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA125118
    Listing Certified Through 2024-12-31

    Package

    NDC 00003-2814-11 (00003281411)

    NDC Package Code 0003-2814-11
    Billing NDC 00003281411
    Package 4 SYRINGE, GLASS in 1 CARTON (0003-2814-11) / .4 mL in 1 SYRINGE, GLASS
    Marketing Start Date 2017-03-30
    NDC Exclude Flag N
    Pricing Information N/A